SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-011693
Filing Date
2021-03-15
Accepted
2021-03-15 19:00:24
Documents
2
Period of Report
2021-03-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3910
2 EX-24 DOCUMENT attachment1.htm EX-24 3976
  Complete submission text file 0000899243-21-011693.txt   9477
Mailing Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140
Business Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140 617-945-5576
Cogent Biosciences, Inc. (Issuer) CIK: 0001622229 (see all company filings)

IRS No.: 465308248 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 2001 MARKET STREET SUITE 2500 PHILADELPHIA PA 19103
Business Address
CAIN CHRISTOPHER W. (Reporting) CIK: 0001817733 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38443 | Film No.: 21743030